CureMetrix Company
CureMetrix is committed to advancing AI-based technology that improves breast cancer and heart disease detection across the globe.
Technology:
Biomarkers of Female Cancers
Industry:
Data processing, General Healthcare, United States
Headquarters:
San Diego, California, United States
Founded Date:
2014-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
2
Estimated Revenue:
$1M to $10M
Last Funding Date:
2017-01-01
Last Funding Type:
Series A
Register and Claim Ownership